ViroCyt Lands $3,467,888 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2100 Central Ave. Boulder, CO 80301 USA
  • Company Description
    ViroCyt’s primary objective is bringing high value solutions to the life science industry that address critical unmet needs. Our first product is the Virus Counter, a revolutionary instrument that allows enumeration of intact viral particles in minutes instead of days or weeks.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy